TD Cowen Reiterates Buy Rating and Top Pick on Revolution (RVMD) Jun 1, 2026 08:28AM
TD Cowen Reiterates Buy Rating on Revolution (RVMD) Apr 28, 2026 10:57AM
Revolution Medicines closes $2.2 billion dual public offerings Apr 17, 2026 04:02PM
Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase Apr 17, 2026 04:02PM
Revolution Medicines prices $2 billion in upsized stock and bond offerings Apr 15, 2026 12:41AM
View Older Stories

Apr 15, 2026 12:41AM Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes
Apr 13, 2026 04:02PM Revolution Medicines announces $1 billion in proposed stock and note offerings
Apr 13, 2026 04:01PM Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes
Feb 24, 2026 04:05PM Revolution Medicines to Participate in TD Cowen 46th Annual Health Care Conference
Dec 3, 2025 08:21AM TD Cowen: 'Revolution (RVMD) Is Our 2026 Best Idea'
Feb 24, 2025 04:05PM Revolution Medicines to Participate in March 2025 Investor Conferences
Dec 5, 2024 04:05PM Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
Dec 4, 2024 06:06AM Revolution Medicines (RVMD) Prices Upsized 14.13M Share Offering at $46/sh
Dec 3, 2024 10:38PM Revolution Medicines Announces Pricing of Upsized $750.0 Million Public Offering of Common Stock and Pre-Funded Warrants
Dec 2, 2024 04:31PM Revolution Medicines (RVMD) Announces Commencement of Public Offering of Common Stock
Dec 2, 2024 04:31PM Revolution Medicines Announces Commencement of Public Offering of Common Stock
Oct 25, 2024 07:10AM TD Cowen Reiterates Buy Rating on Revolution (RVMD)
Jul 16, 2024 07:24AM TD Cowen Reiterates Buy Rating on Revolution (RVMD)
Jun 25, 2024 10:40AM TD Cowen Reiterates Buy Rating on Revolution (RVMD)
Feb 1, 2024 04:05PM Revolution Medicines to Participate in Upcoming Investor Conferences
May 24, 2023 04:05PM Revolution Medicines to Participate in TD Cowen 4th Annual Oncology Innovation Summit
Mar 7, 2023 04:02PM Revolution Medicines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Mar 3, 2023 05:48AM Revolution Medicines (RVMD) Prices 13.64M Share Offering at $22/sh
Mar 2, 2023 09:15PM Revolution Medicines Announces Pricing of $300.0 Million Public Offering of Common Stock
Mar 1, 2023 04:18PM Revolution Medicines (RVMD) Commences Up to $300M Share Offering
Mar 1, 2023 04:17PM Revolution Medicines Announces Commencement of Public Offering of Common Stock
Jul 22, 2022 04:02PM Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jul 22, 2022 04:02PM Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jul 20, 2022 05:47AM Revolution Medicines (RVMD) Prices 11.M Share Offering at $20/sh
Jul 19, 2022 10:41PM Revolution Medicines Announces Pricing of Upsized $230.0 Million Public Offering of Common Stock
Jul 19, 2022 10:41PM Revolution Medicines Announces Pricing of Upsized $230.0 Million Public Offering of Common Stock
Jul 19, 2022 04:01PM Revolution Medicines (RVMD) Announces Commencement of $200M Public Offering of Common Stock
Jul 19, 2022 04:01PM Revolution Medicines Announces Commencement of Public Offering of Common Stock
Jul 19, 2022 04:01PM Revolution Medicines Announces Commencement of Public Offering of Common Stock
Jul 13, 2022 07:00AM Revolution Medicines Appoints Lorence Kim, M.D., Accomplished Health Care Industry Leader, to Board of Directors
Mar 1, 2022 04:05PM Revolution Medicines to Participate in Cowen 42nd Annual Health Care Conference
May 18, 2021 07:30AM Revolution Medicines to Participate in Cowen 2nd Annual Virtual Oncology Innovation Summit
May 18, 2021 07:30AM Revolution Medicines to Participate in Cowen 2nd Annual Virtual Oncology Innovation Summit
Feb 18, 2021 07:30AM Revolution Medicines to Participate in Digital RAS-Targeted Drug Discovery Summit and Upcoming Investor Conferences
Feb 18, 2021 07:30AM Revolution Medicines to Participate in Digital RAS-Targeted Drug Discovery Summit and Upcoming Investor Conferences
Feb 8, 2021 04:01PM Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Feb 4, 2021 05:57AM Revolution Medicines (RVMD) Prices 5.8M Share Common Offering at $45/Sh
Feb 3, 2021 11:30PM Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock
Feb 1, 2021 04:08PM Revolution Medicines (RVMD) to Offer 4M Shares of Common Stock
Feb 1, 2021 04:01PM Revolution Medicines Announces Proposed Public Offering of Common Stock
Aug 10, 2020 07:30AM Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress
Aug 10, 2020 07:30AM Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress
Jul 13, 2020 04:01PM Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jul 9, 2020 05:55AM Revolution Medicines (RVMD) Prices 6M Share Common Offering at $36/Sh
Jul 8, 2020 10:48PM Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock
Jul 6, 2020 04:01PM Revolution Medicines (RVMD) Announces 5.5M Share Proposed Public Offering of Common Stock
Jul 6, 2020 04:01PM Revolution Medicines Announces Proposed Public Offering of Common Stock
Jun 18, 2020 07:30AM Revolution Medicines Appoints Eric T. Schmidt, Ph.D. and Peter Svennilson to its Board of Directors
Jun 18, 2020 07:30AM Revolution Medicines Appoints Eric T. Schmidt, Ph.D. and Peter Svennilson to its Board of Directors
Mar 9, 2020 05:33AM Cowen Starts Revolution (RVMD) at Outperform
View Older Stories